← Human Trials & Peer-Reviewed Studies
Blockade of endogenous growth hormone-releasing hormone receptors dissociates nocturnal growth hormone secretion and slow-wave sleep
Plain-language guide to PMID 15538933 (2004): randomized controlled trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) and GHRH (Growth Hormone-Releasing Hormone).
Key Facts
- PMID
- 15538933
- Journal
- European journal of endocrinology
- Year
- 2004
- Study type
- Randomized Controlled Trial
- Authors
- Jessup SK et al. (4 authors)
- DOI
- 10.1530/eje.0.1510561
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Exogenous HGH, sermorelin & older GHRPs (why they're passed over) and GHRH (Growth Hormone-Releasing Hormone).
A temporal association between non-rapid eye movement (NREM) sleep stages 3 and 4 and nocturnal augmentation of GH release was found long ago, yet the precise mechanism for this association has not been identified.
Based on these data, a role for GHRH as an inducer of SWS was proposed.
To test this hypothesis, the researchers have performed the corollary experiment whereby the action of endogenous GHRH has been antagonized.
Who Took Part
By PubMed's age tags, the people studied were adults, men only.
Healthy men (20-33 years old) had an infusion of GHRH antagonist ((N-Ac-Tyr(1), D-Arg(2)) GHRH-29 (NH(2))) or saline for a 12-h period, between 2100 and 0900 h.
How the Study Was Run
In design terms this was a randomized study.
The participants were allocated by chance, so the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group and the comparison group should start out alike.
A limited montage sleep study was recorded from 2300 to 0700 h during each admission.
Plasma GH concentrations were analyzed by the use of a sensitive chemiluminometric assay.
What Was Measured
PubMed files the paper under topics including Circadian Rhythm, Growth Hormone-Releasing Hormone, Human Growth Hormone, Receptors, Neuropeptide, Receptors, Pituitary Hormone-Regulating Hormone, Sermorelin and Sleep Stages.
What This Means in Plain Language
The paper is a randomized study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over) and GHRH (Growth Hormone-Releasing Hormone).
Results are reported in around 3 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2004 (European journal of endocrinology), a journal based in England.
More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page and the GHRH (Growth Hormone-Releasing Hormone) compound page, all human trials.
Our Notes on the Compounds
Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.
GHRH (Growth Hormone-Releasing Hormone): The 44-amino-acid hypothalamic hormone that tells the pituitary to release growth hormone; sermorelin and tesamorelin are analogs.
Related Pages
- Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in the library
- GHRH (Growth Hormone-Releasing Hormone) in the library
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.